ARCHIVES

In Brief: All 77 New NCI Positions Go to Carcinogenesis Programs; “Not Wisest Way To Use Them” – Newell

This article is from The Cancer Letter archive.

Vol. 03 No. 05 | February 4, 1977

Download PDF Visit The Full Archive

Related Articles

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009

Kimes: Centers Need New $$ Sources; Fox Chase, U.Pa Go Seperate Ways

October 12, 1990

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

Herberman: Progress Made To Stabilize NSABP

September 9, 1994

More Minorities, Women, Fewer MD On Study Sections

September 2, 1988

McKay Retires As Fox Chase Executive, Is Succeeded By Donald Leedy As VP.

June 2, 2000